John K. Field, MA, PhD, BDS, FRCPath
Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Liverpool, UK
Professor John Field, PhD, FRCPath has a Personal Clinical Chair in Molecular Oncology at the University of Liverpool. He is a Visiting Professor at University College London, holds the post of Director of Research of the Roy Castle Lung Cancer Research Programme. He is the Chief Investigator for the UK Lung Cancer Screening Trial (UKLS), Chair of the EU-US Spiral CT collaborative group, Chair (2011- ). He is Chair of the IASLC Screening Prevention & early Detection Committee and the recently formed IASLC Strategic Screening Advisory Group. He was presented with the IASLC Joseph Cullen Award at the WCLC 2011, in recognition of lifetime scientific achievements in lung cancer prevention research. He is Chair of the IASLC Strategic Screening Advisory Committee.
He is the principle investigator of the Liverpool Lung Project, a molecular - epidemiological study into the early detection of lung cancer, funded by the Roy Castle Lung Cancer Foundation. He is also PI on the large EU Early Lung Cancer study funded by the Commission. Both of these trials form part of the NCRI Lung Cancer clinical studies group’s portfolio. Currently, a Partner in the FP7 CURELUNG and LCAOS projects. He is also heavily involved in the identification of molecular diagnostic markers in lung and head & neck cancer. His research funding has been provided mainly by the RCF, NWCRF, MRC, CRUK, EU and HTA.
Professor Field is the author of over 225 international (peer reviewed) papers in his area of expertise and has given more than 270 presentations at medical and scientific conferences around the world.